Negative influence of programmed death‐1‐ligands on the survival of esophageal cancer patients treated with chemotherapy-Reference-Cited by-同舟云学术

Negative influence of programmed death‐1‐ligands on the survival of esophageal cancer patients treated with chemotherapy

Published:2016-05-16 Issue:6 Volume:107 Page:726-733
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Tanaka Koji¹,Miyata Hiroshi¹,Sugimura Keijiro¹,Kanemura Takashi¹,Hamada‐Uematsu Mika²,Mizote Yu²³,Yamasaki Makoto¹,Wada Hisashi¹,Nakajima Kiyokazu¹,Takiguchi Shuji¹,Mori Masaki¹,Doki Yuichiro¹,Tahara Hideaki²

Affiliation:

1. Department of Gastroenterological Surgery Graduate School of Medicine Osaka University Suita OsakaJapan

2. Department of Surgery and Bioengineering Advanced Clinical Research Center Institute of Medical Science University of Tokyo TokyoJapan

3. Sanofi K.K. Tokyo Japan

Funder

Japanese Ministry of Education, Culture, Sports Science and Technology

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12938

Reference34 articles.

1. Global Cancer Statistics, 2002

2. Survival Factors in Patients with Recurrence After Curative Resection of Esophageal Squamous Cell Carcinomas

3. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy

4. Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal Cancer

5. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Clinical Trial Results of the Recently Approved Immunotherapeutic Drugs for Advanced Biliary Tract Cancers;Reviews on Recent Clinical Trials;2024-05

2. Impacts of tumor microenvironment during neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma;Cancer Science;2024-05

3. Programmed cell death-ligand 2: new insights in cancer;Frontiers in Immunology;2024-03-28

4. Loss of SATB2 expression correlates with cytokeratin 7 and PD-L1 tumor cell positivity and aggressiveness in colorectal cancer;Scientific Reports;2022-11-09

5. Change in PD-L1 and CD8 Expression after Chemoradiotherapy for Esophageal Squamous Cell Carcinoma;Biomedicines;2022-08-04